Janux Therapeutics (NASDAQ: JANX)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Janux Therapeutics (NASDAQ: JANX) through any online brokerage.
The latest price target for Janux Therapeutics (NASDAQ: JANX) was reported by Cantor Fitzgerald on Friday, August 12, 2022. The analyst firm set a price target for 4.00 expecting JANX to fall to within 12 months (a possible -69.54% downside). 50 analyst firms have reported ratings in the last year.
The stock price for Janux Therapeutics (NASDAQ: JANX) is $13.13 last updated August 12, 2022, 8:00 PM UTC.
The next Janux Therapeutics (JANX) dividend date is projected to be Thursday, September 1, 2022.
Janux Therapeutics’s FY earnings are confirmed for Wednesday, December 20, 2023.
There is no upcoming split for Janux Therapeutics.
Janux Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.